Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

NCT07088757 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1366

Enrollment

OTHER

Sponsor class

Conditions

Post-ERCP Pancreatitis

Interventions

DRUG: standard dose indomethacin
DRUG: low dose indomethacin

Sponsor

Changhai Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]